RDTCF (Rapid Dose Therapeutics) Market Cap : $20.68 Mil (As of Dec. 14, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rapid Dose Therapeutics's share price for the quarter that ended in Aug. 2024 was $0.008. Rapid Dose Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Aug. 2024 was 124.64 Mil. Therefore, Rapid Dose Therapeutics's market cap for the quarter that ended in Aug. 2024 was $1.00 Mil.

Rapid Dose Therapeutics's quarterly market cap declined from Feb. 2024 ($1.78 Mil) to May. 2024 ($0.35 Mil) but then increased from May. 2024 ($0.35 Mil) to Aug. 2024 ($1.00 Mil).

Rapid Dose Therapeutics's annual market cap declined from Feb. 2022 ($20.61 Mil) to Feb. 2023 ($0.04 Mil) but then increased from Feb. 2023 ($0.04 Mil) to Feb. 2024 ($1.78 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rapid Dose Therapeutics's Enterprise Value for Today is $22.57 Mil.

Rapid Dose Therapeutics Market Cap Historical Data

The historical data trend for Rapid Dose Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Market Cap Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Market Cap

Get a 7-Day Free Trial

17.73

15.04

20.61

0.04

1.78

Rapid Dose Therapeutics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Market Cap	Get a 7-Day Free Trial															2.59	11.54	1.78	0.35	1.00

Competitive Comparison of Rapid Dose Therapeutics's Market Cap

For the Biotechnology subindustry, Rapid Dose Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Market Cap falls into.

Rapid Dose Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Rapid Dose Therapeutics's Market Cap for the fiscal year that ended in Feb. 2024 is calculated as

Market Cap (A: Feb. 2024 )	=	Share Price (A: Feb. 2024 )	*	Shares Outstanding (EOP) (A: Feb. 2024 )
	=	$0.0151	*	117.81
	=	$1.78

Rapid Dose Therapeutics's Market Cap for the quarter that ended in Aug. 2024 is calculated as

Market Cap (Q: Aug. 2024 )	=	Share Price (Q: Aug. 2024 )	*	Shares Outstanding (EOP) (Q: Aug. 2024 )
	=	$0.008	*	124.636
	=	$1.00

Rapid Dose Therapeutics (OTCPK:RDTCF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Rapid Dose Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.